Peginterferon - Novartis announces in-licensing of valopicitabine (NM283), a novel

Novartis announces in-licensing of valopicitabine (NM283), a novel
WebWire - * Novartis strengthens infectious disease portfolio and range of hepatitis compounds * Valopicitabine (NM283) the most advanced oral, direct antiviral compound in development for treatment of hepatitis C * More than 170 million patients worldwide

Shelter Director Turns "Small Hobby" into Career
Bradley News Weekly - Gene Smith's morning began with a complaint call on several dogs that were running loose. The owner had already been cited many times as being in violation of Cleveland's leash law but for some reason hadn't gotten the message. From there, Smith

Influenza Vaccination and False Positive HIV Results
New England Journal of Medicine - To the Editor: Six weeks after an occupational needle-stick injury, a 35-year-old man presented to a clinic in the Los Angeles area for testing to rule out acute infection with the human immunodeficiency virus (HIV). The patient had no other risk

Chinese Patients With Chronic Hepatitis B Respond Better To
Medical News Today - Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) and Novartis (NYSE: NVS) today announced new data that demonstrate telbivudine, an investigational oral, once-daily nucleoside analogue, provided significantly greater antiviral and clinical efficacy in

Nixing the Need for the Needle
Wired News - New technology for delivering drugs is doing away with one of the most feared, yet enduring, symbols of modern medicine -- the hypodermic needle. In January, drug giant Pfizer won approval to market inhalable insulin, a product that in three years is